|Other Names||Uridine-cytidine kinase-like 1, UCKL1, URKL1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP7193b was selected from the C-term region of human URKL1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||May contribute to UTP accumulation needed for blast transformation and proliferation.|
|Cellular Location||Cytoplasm. Nucleus. Note=EBNA3 induces isoform 1 translocation to the nucleus, whereas it does change isoform 3 location|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Uridine kinase is a key enzyme in the pyrimidine salvage pathway of all mammalian cells. URKL1 (uridine kinase-like 1) is highly similar in structure and sequence to uridine kinase.
Kashuba, E., et al., (er) BMC Cell Biol. 3 (1), 23 (2002) (): ().
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.